HER2 Mutation
Interviews and expert commentary tagged “HER2 Mutation” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Xiuning Le MD PhD; ESMO 2025: Sevabertinib Success for Patients with HER2-Mutated Non-Small Cell Lung Cancer in SOHO-01 Study
A new anti cancer drug sevabertinib, that targets mutated HER2, has proved effective in the SOHO-01 study among patients wiith HER2 mutated non small cell lung cancer. It has now been reported in the
31 October 2025
0:00